South Africa Liposomal Doxorubicin Market Size & Outlook
Related Markets
South Africa liposomal doxorubicin market highlights
- The South Africa liposomal doxorubicin market generated a revenue of USD 9.1 million in 2024 and is expected to reach USD 13.1 million by 2033.
- The South Africa market is expected to grow at a CAGR of 4.2% from 2025 to 2033.
- In terms of segment, lipodox was the largest revenue generating product in 2024.
- Lipodox is the most lucrative product segment registering the fastest growth during the forecast period.
Liposomal doxorubicin market data book summary
| Market revenue in 2024 | USD 9.1 million |
| Market revenue in 2033 | USD 13.1 million |
| Growth rate | 4.2% (CAGR from 2025 to 2033) |
| Largest segment | Lipodox |
| Fastest growing segment | Lipodox |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Doxil/Caelyx, Lipodox, Myocet |
Other key industry trends
- In terms of revenue, South Africa accounted for 0.7% of the global liposomal doxorubicin market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Middle East & Africa, South Africa liposomal doxorubicin market is projected to lead the regional market in terms of revenue in 2033.
- Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 12.0 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Liposomal Doxorubicin Market Scope
Liposomal Doxorubicin Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| SRS Life Sciences | View profile | 51-100 | Singapore, Central Region, Singapore, Asia | https://www.srslife.com |
| Shanghai Fudan-Zhangjiang Bio-Pharmaceutical | View profile | 501-1000 | Shanghai, Shanghai, China, Asia | http://www.fd-zj.com/desktopmodules/ht/English/home/Index.aspx |
| Cipla | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | http://www.cipla.com |
| Cadila Pharmaceuticals | View profile | 5001-10000 | Ahmedabad, Gujarat, India, Asia | http://cadilapharma.com |
| Sun Pharmaceutical Industries | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | http://www.sunpharma.com |
| Lupin | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | https://www.lupin.com |
| GSK PLC | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
South Africa liposomal doxorubicin market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to liposomal doxorubicin market will help companies and investors design strategic landscapes.
Lipodox was the largest segment with a revenue share of 40.66% in 2024. Horizon Databook has segmented the South Africa liposomal doxorubicin market based on doxil/caelyx, lipodox, myocet covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to South Africa liposomal doxorubicin market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Africa liposomal doxorubicin market databook
-
Our clientele includes a mix of liposomal doxorubicin market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa liposomal doxorubicin market , including forecasts for subscribers. This country databook contains high-level insights into South Africa liposomal doxorubicin market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
South Africa liposomal doxorubicin market size, by product, 2021-2033 (US$M)
South Africa Liposomal Doxorubicin Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
